Résultats de la recherche - Jae‐Soo Shin
- Résultat(s) 1 - 3 résultats de 3
-
1
-
2
The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model par Saebom Lee, Sangjune Kim, Yong Joo Park, Seung Pil Yun, Seung‐Hwan Kwon, Donghoon Kim, Dong-Yeon Kim, Jae Soo Shin, Dae Jin Cho, Gong Yeal Lee, Hyun Ju, Hyo Jung Yun, Jae Hong Park, Richard W. Kim, Eun Ah Jung, Seulki Lee, Han Seok Ko
Publié 2018Artigo -
3
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors par S.-H. Kim, Hari Menon, Saengsuree Jootar, T Saikia, J. Kwak, S.K. Sohn, J. S. Park, Seong Hyun Jeong, Hyung‐Jun Kim, Y.-K. Kim, Subi Oh, Heonoh Kim, Dae Young Zang, Joo-Seop Chung, Hyeon Ju Shin, Yashwant Lamture, Jeong‐Ah Kim, D.-Y. Kim, Chul Won Choi, Sung Sup Park, H. L. Park, G. Y. Lee, Dongwook Cho, Jae‐Soo Shin, D.-W. Kim
Publié 2014Artigo
Outils de recherche:
Sujets similaires
Biology
Biochemistry
Internal medicine
Medicine
Adverse effect
Cancer
Capsaicin
Cell biology
Chemistry
Chromosomal translocation
Chronic myelogenous leukemia
Dephosphorylation
Desensitization (medicine)
Disease
Gastroenterology
Gene
Homologous desensitization
Imatinib
Imatinib mesylate
Immunology
Leukemia
Myeloid leukemia
Neuroprotection
Parkinson's disease
Pharmacology
Philadelphia chromosome
Phosphatase
Phosphorylation
Receptor
Resiniferatoxin